Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Explore how to help ensure early detection and treatment of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS). Earn CNE credits and start learning today!
Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are endocrine emergencies. Hospitalizations for diabetes and DKA are rising, possibly because of increased diabetes prevalence and higher insulin costs. HHS is associated with high mortality risks, which is particularly worrisome during the COVID-19 pandemic, when healthcare resources have been stretched thin. To help ensure early identification and treatment of these conditions, this article provides an overview of both.
Key Learning Outcomes
- Compare onset, diagnosis, and treatment of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS).
- Identify special considerations for preventing DKA recurrence.
Lindsay K. Buchert, MSN, RN, ANP-BC
Lindsay K. Buchert is an adult nurse practitioner with the inpatient
endocrine service in the department of internal medicine at Atrium Health Carolinas Medical Center in Charlotte, North Carolina.